GENE ONLINE|News &
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
A recent study indicates that digoxin, a long-established cardiac medication, demonstrably lowers the risk of death from any cause and the development or exacerbation of heart failure in patients with symptomatic rheumatic heart disease (RHD). Researchers published these unexpected findings on the eve of […].
The study challenges common beliefs about cardiovascular treatments. Scientists found that digoxin, a cardiac glycoside used for over a century, had a positive impact on RHD patients. The results suggest a potential new approach to managing this specific heart condition.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 10, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Hilton Partners With Big Brothers Big Sisters to Provide Hospitality Career Training for Youth
2026-06-18
Pacific Life Launches Income Horizon Collective Investment Trust Series for Retirement Plans
2026-06-18
Synovis Micro Companies Alliance to Distribute MediThinQ SHIYA 3D Visualization Platform Globally
2026-06-18
Diamond Estates Wines & Spirits Inc. Renews Investor Relations Agreement with Atrium Research
2026-06-18
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
